Core Viewpoint - EssilorLuxottica and Dolce&Gabbana have extended their partnership through 2050 for the development, production, and global distribution of prescription frames and sunglasses under the Dolce&Gabbana brand [2]. Group 1: Partnership Details - The new agreement reflects a long-term collaboration model, emphasizing deep integration of values, strategic vision, and product culture [3]. - The partnership, which began in 2004, has successfully combined strong business results with creative vision [4]. - The extension of the partnership indicates mutual confidence in future opportunities for both companies [4]. Group 2: Company Strengths - EssilorLuxottica is recognized for its expertise in eyewear manufacturing, high-quality retail and distribution network, and focus on technological innovation [4]. - Dolce&Gabbana expresses pride in further strengthening the partnership, highlighting the brand's iconic status in the fashion industry [4].

Core Insights - Safilo Group has demonstrated resilience amid tariff and foreign exchange challenges, with improved sales and margins in the first nine months of 2025, driven by strong performance in Asia-Pacific and Europe [1][4]. Financial Performance - Sales for the first nine months of 2025 increased slightly by 0.1 percent to 758.4 million euros from 757.4 million euros year-over-year, with a 2.2 percent rise at constant exchange rates [2]. - In the third quarter, sales decreased by 2.1 percent to 220.8 million euros compared to 225.4 million euros in the same period last year, but were up 2.1 percent at constant exchange rates [3]. - Gross profit in the third quarter totaled 131.7 million euros, a decrease of 1.2 percent year-over-year, while gross margin improved by 60 basis points to 59.7 percent [3]. Regional Performance - Prescription frames sales grew across all regions, with sunglass sales particularly boosting performance in Europe. Brands such as Carrera, David Beckham, and Marc Jacobs contributed positively [4]. - Sales in Europe rose by 3 percent to 334 million euros in the first nine months, while Asia-Pacific sales surged by 9.9 percent to 44 million euros [10]. - North American sales fell by 1.1 percent to 317.8 million euros, with a significant decline of 6.6 percent in the third quarter [11]. Margin and EBITDA - The adjusted EBITDA margin in the third quarter increased by 210 basis points to 10 percent from 7.9 percent year-over-year, with adjusted EBITDA rising 24.3 percent to 22.1 million euros [5]. - The company attributed margin improvements to effective mitigation actions against tariffs and favorable price/mix dynamics [6]. Debt and Cash Flow - As of September 30, net debt decreased to 30.4 million euros from 42.4 million euros at the end of June, with a positive adjusted figure of 10.7 million euros before IFRS 16 application [7][12]. - Free cash flow increased to 20.7 million euros in the third quarter, up from 16.9 million euros in the same period of 2024 [12].